Ovarian PRP and 'Ovarian Rejuvenation': What Is Experimental and What Is Known?

Key Takeaways

• Ovarian PRP is experimental. It is not an established treatment for improving the chance of having a baby.
• A change in AMH or menstrual periods does not prove that egg quality or live birth chances have improved.
• Injection into the ovaries carries risks, and delaying established fertility care can matter.
• Ask about research oversight, total costs, alternatives and the plan if the procedure does not help.

If you have been offered ovarian PRP treatment after a low AMH result or an IVF cycle with few eggs, you may feel hopeful and unsure. You deserve an explanation that separates a promising idea from a treatment proven to help you have a baby.

Ovarian PRP and 'Ovarian Rejuvenation': What Is Experimental and What Is Known?

“Ovarian rejuvenation” sounds as if an ovary can be made younger. That is not an established medical outcome. The phrase is used for experimental approaches, including platelet-rich plasma, or PRP, injected into the ovaries.

PRP is prepared from your own blood. It contains a higher concentration of platelets, which release growth factors involved in tissue repair. Researchers are studying whether these signals might influence the ovarian environment.

That biological idea is not proof that PRP creates new eggs, reverses age-related changes or restores fertility after menopause. Those claims go beyond reliable evidence.

How Is Ovarian PRP Treatment Done?

Protocols vary between centres, which makes research results harder to compare. Generally, the proposed procedure involves these steps:

• A blood sample is taken from your arm.
• A centrifuge separates the blood components to prepare PRP.
• A doctor uses ultrasound guidance to inject PRP into ovarian tissue, usually through the vagina.
• Sedation or anaesthesia may be used, with monitoring and recovery instructions afterwards.

This is different from PRP placed inside the uterus, which is studied for other fertility concerns. Evidence about one procedure cannot be used to promise benefits from the other.

Preparation methods, platelet concentration, injection volume and follow-up schedules are not standardised. There is no universally accepted protocol proven to improve live birth rates.

What Does the Research Actually Tell Us?

Some studies have reported changes in AMH, antral follicle count, menstrual activity or the number of eggs collected. Pregnancies have also been reported after PRP. These findings justify research, but they do not establish that PRP caused the improvement.

Many studies are small or lack a suitable comparison group. Ovarian response can vary naturally between cycles. Changes in IVF medicines, participant selection and reporting methods can also affect results.

Controlled research has not established a reliable live birth benefit. Ovarian PRP treatment remains experimental, rather than a routine, evidence-based add-on to IVF.

• AMH: Helps estimate ovarian response, but does not directly measure egg quality.
• Egg numbers: More eggs do not automatically mean more usable embryos or a baby.
• Pregnancy reports: Cannot show benefit without an appropriate comparison.
• Live birth: This is the outcome couples need clear evidence about.

For example, if your AMH rises after a procedure but your next IVF cycle produces the same number of mature eggs, the blood result alone should not be presented as proof of success.

Who Is Usually Offered It?

You may hear about ovarian PRP treatment if you have diminished ovarian reserve, a previous poor response to IVF stimulation or premature ovarian insufficiency. These conditions are not interchangeable, and each needs a proper assessment.

Low AMH does not mean pregnancy is impossible. It mainly helps predict egg yield during stimulation. Your age, scan findings, menstrual history, sperm factors and previous treatment results also matter.

Premature ovarian insufficiency needs care beyond fertility treatment, including attention to hormonal symptoms and longer-term health. Occasional ovarian activity can occur without PRP, so a returning period does not prove that an injection worked.

What Is Known, and What Remains Uncertain?

Risks Include More Than the Injection

Possible complications include pain, bleeding, infection, injury to nearby structures and risks related to sedation or anaesthesia. Long-term safety information for injection into ovarian tissue is limited.

Using your own blood reduces some concerns about reactions to donor material. It does not remove risks from blood handling, preparation or the injection itself. Sterile technique and appropriate facilities still matter.

There is also the cost of waiting. If you are older or have limited ovarian reserve, spending months repeating an unproven procedure may delay care with more established evidence.

After any ovarian procedure, severe or worsening abdominal pain, fever, faintness or heavy bleeding needs urgent medical assessment. Ask for written aftercare instructions and an emergency contact before leaving.

Questions to Ask Before Giving Consent

You do not need to agree on the day a procedure is suggested. Take the written information home and discuss it with your partner if you wish.

• Is this part of an ethically approved, registered clinical study?
• What evidence applies to someone of my age and diagnosis?
• Are you discussing live births, pregnancies or only hormone changes?
• What are the total charges, including tests, sedation and follow-up?
• Could waiting reduce my options, and what happens if PRP does not help?
• Who will manage a complication, and where will that care happen?

Research participation should include clear consent and oversight, without promises of benefit. Be cautious if you are guaranteed younger ovaries, new eggs or pregnancy.

Planning Fertility Care in Delhi NCR

A doctor will decide which options are medically suitable after reviewing your records. These may include adjusting an IVF treatment plan, discussing donor eggs where appropriate, or reassessing the diagnosis before further treatment.

If you are considering egg freezing, ask what your age and ovarian reserve mean for likely egg yield. PRP should not be presented as a proven way to improve that outcome.

For a consultation at Pravi Global IVF, bring earlier scans, hormone reports and IVF cycle summaries. Knowing how many eggs were mature and how embryos developed is more useful than an AMH number alone.

The clinic is at E-3, 3rd Floor, Lajpat Nagar 2, New Delhi. People coming from across Delhi NCR often use Metro interchanges to reach Lajpat Nagar station, on the Violet and Pink lines, then arrange the onward connection.

If you drive from Noida, Faridabad or Gurugram, allow extra time depending on traffic, especially around market hours. For any procedure involving sedation, confirm fasting instructions and arrange an adult escort; do not plan to drive yourself home.

Frequently Asked Questions

Is ovarian PRP treatment proven to improve pregnancy chances?

No reliable live birth benefit has been established. It remains experimental, and hormone changes should not be described as proof that it will help you conceive.

Can PRP increase AMH permanently?

Some studies report changes, but a predictable, lasting increase is not established. A higher AMH result does not prove better egg quality.

Does PRP reverse menopause?

No. It has not been proven to reverse menopause or replenish the egg supply. Bleeding after menopause needs medical assessment, not an assumption that fertility has returned.

Should I delay IVF to try PRP?

Do not delay without discussing the trade-off with your doctor. Your age, previous response and reproductive plans affect how much waiting may matter.

Is it safe because it uses my own blood?

Your own blood does not make the procedure risk-free. Injection, blood preparation and sedation each carry possible risks, and long-term ovarian safety remains uncertain.

For a discussion of your reports and options at Pravi Global IVF, call +91 80091 50040 or book an appointment. You can ask for an explanation before deciding.